Rad50-flox 基因敲除小鼠

1. Sheikh, Asfandyar, Hussain, Syed Ather, Ghori, Quratulain, Mainali, Prajeena, Al Tamimi, Dalal M. . The spectrum of genetic mutations in breast cancer. In Asian Pacific journal of cancer prevention : APJCP, 16, 2177-85. doi:. https://pubmed.ncbi.nlm.nih.gov/25824734/

2. Karamat, Uzma, Ejaz, Samina. . Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients. In Current cancer drug targets, 21, 163-176. doi:10.2174/1568009620666201009125507. https://pubmed.ncbi.nlm.nih.gov/33038913/

3. Li, Yinuo, Wang, Shourong, Li, Peng, Liu, Zhaojian, Kong, Beihua. 2021. Rad50 promotes ovarian cancer progression through NF-κB activation. In Journal of cellular and molecular medicine, 25, 10961-10972. doi:10.1111/jcmm.17017. https://pubmed.ncbi.nlm.nih.gov/34734468/

4. Walsh, Tom, Casadei, Silvia, Lee, Ming K, King, Mary-Claire, Swisher, Elizabeth M. 2011. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. In Proceedings of the National Academy of Sciences of the United States of America, 108, 18032-7. doi:10.1073/pnas.1115052108. https://pubmed.ncbi.nlm.nih.gov/22006311/